# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Isaac Newton (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN011-SYN-TD
- Date: 1693-09-28
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rupert Okonkwo-Fairbanks, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Primary care visit for a year of poor sleep and appetite, two weeks of near-sleeplessness, and suspicious thoughts about friends, in a researcher who heats mercury and other metals. **S**

## Historical basis

- Isaac Newton was born at Woolsthorpe, in the parish of Colsterworth, Lincolnshire, on Christmas Day 1642 (25 December 1642 in the Julian calendar then used in England; 4 January 1643 in the Gregorian calendar), the only son of Isaac, a farmer, and his wife Hannah Ayscough. His father died before he was born, and his mother later remarried and had three more children. **D**
- He was educated at Grantham and at Trinity College, Cambridge, became a Fellow of Trinity in 1667, held the Lucasian Professorship of Mathematics from 1669 to 1702, and was elected a Fellow of the Royal Society in 1672. **D**
- His biographer David Brewster, working from Newton's manuscripts, wrote that he was deeply engaged in chemical experiments in December 1692 and January 1693. Among his papers is a one-page manuscript in his hand titled 'Notes on mercury and its purification'. **D**
- Brewster wrote that from the autumn of 1692 Newton complained of loss of appetite and want of sleep, which continued for nearly a twelvemonth. **D**
- On 13 September 1693 (Julian; 23 September, Gregorian) Newton wrote to Samuel Pepys that he was 'extremely troubled at the embroilment I am in, and have neither ate nor slept well this twelvemonth, nor have my former consistency of mind', that he had never designed to get anything by Pepys's interest or the King's favour, and that he must withdraw from Pepys's acquaintance and see neither him nor the rest of his friends any more. **D**
- On 16 September 1693 (Julian; 26 September, Gregorian), writing from the Bull in Shoreditch, London, he told John Locke that, being of opinion that Locke had endeavoured to embroil him with women and by other means, he had answered, when told Locke was sickly and would not live, that 'twere better if you were dead'. He begged Locke's pardon for this, for representing that Locke's book struck at the root of morality and taking him for a Hobbist, and for saying or thinking that there was a design to sell him an office or to embroil him; he signed himself Locke's 'most humble and unfortunate servant'. **D**

10 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- He has barely slept for two weeks, eats little, and feels he has lost his former steadiness of mind. **S**
- He wrote angry letters to friends he now thinks he wronged, and wants to make amends. **S**
- He asks whether the metals in his laboratory have poisoned him. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- No medications before this visit. **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- Autumn 1692 (Julian): Loss of appetite and want of sleep from the previous autumn, continuing for nearly a year, by his biographer's account **D** (CLM-0004)

## Procedures and immunizations

- No procedures before this visit. **S**
- 1687-06-15: Tdap vaccine **S**
- 1686-03-04: Hepatitis B vaccine, two-dose adult series completed **S**

## Family history

- father: Died before the patient was born; cause not recorded in the cited source **D** (CLM-0001)

## Measurements

PHQ-9: 20; GAD-7: 11; MoCA: 27; Hemoglobin: 14.6 g/dL; MCV: 91 fL; White blood cells: 6.1 10*3/uL; Platelets: 242 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.3 mmol/L; BUN: 15 mg/dL; Creatinine: 0.92 mg/dL; eGFR: 101 mL/min/1.73 m²; Glucose: 88 mg/dL; Calcium: 9.5 mg/dL; Albumin: 4.2 g/dL; ALT: 24 U/L; TSH: 1.9 mIU/L; Vitamin B12: 455 pg/mL; Urine albumin-to-creatinine ratio: 9 mg/g{creat}; Blood mercury: 9.4 ug/L (high); Blood lead: 2.4 ug/dL; 24-hour urine mercury: 46 ug/L (high); Urine mercury per gram creatinine: 41 ug/g{creat} (high). All results are synthetic.

BP 124/78 mmHg; pulse 84 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 64 kg; BMI 22.1 kg/m². All vital signs are synthetic.

## Examination

Mental status: Thin, slightly unkempt, tired; guarded at first, then courteous and engaged; speech normal in rate and volume; no psychomotor agitation or slowing; Mood "out of sorts and worn down"; affect constricted and anxious; thought process linear; preoccupied with the belief that a friend tried to entangle him in gossip and that others planned to buy him off with a post, which he now partly doubts ("I may have been unjust"); no fixed delusions; no hallucinations; no thoughts of death or self-harm; he once said in anger that a friend would be better dead, regrets it, and has no thoughts or intent of harming anyone; MoCA 27; insight partial and improving; judgment fair. Functional status: Independent in all activities of daily living; still teaching, but has stopped answering letters, eats one small meal a day, and has spent nights at the furnace or lying awake. Physical examination is intentionally limited. **S**

## Safety assessment

Current ideation: absent; intent: absent; plan: absent; access reviewed: yes. Disposition: No suicidal ideation, intent, plan, or behavior (C-SSRS screen negative; PHQ-9 item 9 scored 0). No thoughts or intent of harming others; an angry remark about a friend is regretted, with no history of violence. Severe insomnia and depressive symptoms raise risk, so: outpatient care with a safety plan, the 988 Suicide & Crisis Lifeline and the clinic number, the laboratory closed today and its mercury and arsenic compounds to be removed by the university safety office, and review at every visit. This is synthetic and does not convert historical behavior into a current finding. **S**

## Assessment

1. A year of poor sleep and poor appetite with 4 kg weight loss, two weeks of near-total sleeplessness, low spirits, and suspicious thoughts that colleagues and friends were plotting against him, now partly doubted; under evaluation for depression, a toxic cause, and other medical causes; status draft. **S**
2. Occupational exposure to elemental and inorganic mercury, with lesser exposure to lead, antimony, and arsenic compounds, from heating metals in an unventilated private laboratory; status draft. **S**

## Plan

- Workup for medical and toxic causes: blood count, metabolic panel, TSH, vitamin B12, MoCA, urine albumin-to-creatinine ratio and dipstick protein, blood mercury, 24-hour urine mercury with creatinine, and blood lead; examination for tremor, gingivitis, stomatitis, and neuropathy; no provoked (chelator-challenge) urine test and no broad metal screen. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); Evaluating Mercury Exposure: Information for Health Care Providers (2018); NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026); American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010); Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013) **S**
- Removal from exposure now: stop all heating of metals, close the laboratory, and do not sleep in the adjoining rooms until they are checked; the university environmental health and safety office to measure mercury vapor, decontaminate, and remove the mercury and arsenic compounds. Guideline: Evaluating Mercury Exposure: Information for Health Care Providers (2018); NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026); American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010); Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013) **S**
- Suicide and violence risk assessment with a safety plan: warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; toxic chemicals out of reach; safety reviewed at every visit. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Occupational and environmental medicine (medical toxicology) consultation on the meaning of the mercury results, chelation, the workplace hazard assessment, and a safe return to laboratory work. Guideline: Evaluating Mercury Exposure: Information for Health Care Providers (2018); NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026); American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010); Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013) **S**
- Sleep: cognitive behavioral therapy for insomnia (a fixed rising time, a sleep window, out of bed after 20 minutes awake, no dozing in the evening chair, no night work); no hypnotics or sedating antihistamines. Guideline: Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016) **S**
- Nutrition: three regular meals a day, weight at every visit. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022) **S**

## Guideline basis

- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), American Psychological Association
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016), American College of Physicians (Annals of Internal Medicine)
- Evaluating Mercury Exposure: Information for Health Care Providers (2018), Agency for Toxic Substances and Disease Registry
- NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026), National Institute for Occupational Safety and Health
- American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010), American College of Medical Toxicology (Journal of Medical Toxicology)
- Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013), American College of Medical Toxicology (Journal of Medical Toxicology)
